title: High intrafamilial variability in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy: a case study.
abstract: BACKGROUND
  Autoimmune polyendocrinopathy- candidiasis-ectodermal-dystrophy syndrome (APECED) is a monogenic disease whose phenotype may reveal wide heterogeneity. The reasons of this variability still remain obscure.
  
  
  METHODS
  Two APECED siblings with identical genotype and extremely different phenotype were compared with regard to exposure to infectious triggers, autoantibodies' profile, mechanisms of peripheral tolerance, and human leukocyte antigen (HLA) haplotype. The following infectious markers were evaluated: rubella, Epstein Barr virus, cytomegalovirus, toxoplasma, varicella zoster virus, parvovirus B19, herpes simplex virus, and parainfluenza virus. APECED-related autoantibodies were detected by indirect immunofluorescence or complement fixation or enzyme- linked immunosorbent assay or radioimmunoassay. Resistance to Fas-induced apoptosis was evaluated on peripheral blood mononuclear cells (PBMC) activated with phytohemoagglutinin, the number of TCD4+CD25+ regulatory cells (Treg) was evaluated through flow-cytometry and natural killer (NK) activity through Wallac method. Perforin (PRF1) was amplified by PCR and sequenced.
  
  
  RESULTS
  No difference was observed between the siblings in common infectious triggers, extent of Fas-induced apoptosis, NK-cell activity and PRF1 sequence, the number of Tregs and HLA haplotypes.
  
  
  CONCLUSIONS
  Although APECED is a monogenic disease, its expressivity may be extremely different even in the same family. This variability cannot be explained by common triggering infectious agents or functional alterations of mechanisms governing peripheral tolerance.
authors.affiliation: Department of Pediatrics, Federico II University, Naples, Italy.
authors.forename: D
authors.initials: D
authors.lastname: Capalbo
authors.forename: A
authors.initials: A
authors.lastname: Fusco
authors.forename: G
authors.initials: G
authors.lastname: Aloj
authors.forename: N
authors.initials: N
authors.lastname: Improda
authors.forename: L
authors.initials: L
authors.lastname: Vitiello
authors.forename: U
authors.initials: U
authors.lastname: Dianzani
authors.forename: C
authors.initials: C
authors.lastname: Betterle
authors.forename: M
authors.initials: M
authors.lastname: Salerno
authors.forename: C
authors.initials: C
authors.lastname: Pignata
mesh_terms: D001323:Autoantibodies / Q000276:immunology; D002177:Candidiasis / Q000235:genetics* / Q000276:immunology*; D002675:Child, Preschool; D005260:Female; D019084:Fluorescent Antibody Technique, Indirect; D020022:Genetic Predisposition to Disease; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000276:immunology; D008297:Male; D061166:Peripheral Tolerance / Q000235:genetics / Q000276:immunology*; D010641:Phenotype; D016884:Polyendocrinopathies, Autoimmune / Q000235:genetics* / Q000276:immunology*; D011863:Radioimmunoassay; D035781:Siblings
chemical_list: D001323:Autoantibodies
references.citation: Diabetes. 2001 Mar;50(3):483-8
references.pmid: 11246866
references.citation: Virology. 2000 Jun 5;271(2):276-88
references.pmid: 10860882
references.citation: Nat Immunol. 2003 Apr;4(4):350-4
references.pmid: 12612579
references.citation: Immunity. 2004 May;20(5):509-16
references.pmid: 15142520
references.citation: Immunity. 1994 Jun;1(3):231-42
references.pmid: 7889411
references.citation: J Clin Endocrinol Metab. 2006 Aug;91(8):2843-50
references.pmid: 16684821
references.citation: Genes Immun. 2008 Jul;9(5):438-44
references.pmid: 18496551
references.citation: Nat Rev Immunol. 2002 Jan;2(1):11-9
references.pmid: 11908514
references.citation: Pediatr Res. 1998 Jan;43(1):77-83
references.pmid: 9432116
references.citation: Diabetes. 2008 Apr;57(4):1078-83
references.pmid: 18198357
references.citation: J Clin Endocrinol Metab. 1998 Apr;83(4):1049-55
references.pmid: 9543115
references.citation: Arthritis Res Ther. 2005;7(6):R1360-74
references.pmid: 16277689
references.citation: Annu Rev Immunol. 2009;27:287-312
references.pmid: 19302042
references.citation: J Clin Endocrinol Metab. 1996 May;81(5):1871-6
references.pmid: 8626850
references.citation: Trends Immunol. 2003 Nov;24(11):584-8
references.pmid: 14596882
references.citation: J Clin Endocrinol Metab. 1997 May;82(5):1440-6
references.pmid: 9141530
references.citation: J Clin Endocrinol Metab. 2002 Jun;87(6):2568-74
references.pmid: 12050215
references.citation: Clin Endocrinol (Oxf). 2008 Sep;69(3):511-3
references.pmid: 18248641
references.citation: Eur J Endocrinol. 2004 Mar;150(3):313-21
references.pmid: 15012616
references.citation: J Clin Endocrinol Metab. 2000 Dec;85(12):4434-40
references.pmid: 11134089
references.citation: J Immunol. 2007 Jan 15;178(2):1208-15
references.pmid: 17202386
references.citation: Am J Hum Genet. 2002 Nov;71(5):1017-32
references.pmid: 12395298
references.citation: Nature. 2005 Jun 2;435(7042):590-7
references.pmid: 15931211
references.citation: Clin Genet. 2006 Oct;70(4):348-54
references.pmid: 16965330
references.citation: Gut. 1985 Mar;26(3):285-90
references.pmid: 3156076
references.citation: Immunity. 2001 Jul;15(1):137-47
references.pmid: 11485745
references.citation: Nat Med. 1998 Jul;4(7):781-5
references.pmid: 9662368
references.citation: J Clin Endocrinol Metab. 2007 Feb;92(2):595-603
references.pmid: 17118990
references.citation: Eur J Immunogenet. 1995 Oct;22(5):403-11
references.pmid: 8589046
references.citation: Am J Pathol. 2003 Oct;163(4):1341-55
references.pmid: 14507643
references.citation: J Immunol. 2005 Feb 15;174(4):1862-70
references.pmid: 15699112